380 related articles for article (PubMed ID: 28770597)
21. The effectiveness and cost implications of task-shifting in the delivery of antiretroviral therapy to HIV-infected patients: a systematic review.
Mdege ND; Chindove S; Ali S
Health Policy Plan; 2013 May; 28(3):223-36. PubMed ID: 22738755
[TBL] [Abstract][Full Text] [Related]
22. Acceleration of differentiated service delivery for HIV treatment in sub-Saharan Africa during COVID-19.
Grimsrud A; Wilkinson L
J Int AIDS Soc; 2021 Jun; 24(6):e25704. PubMed ID: 34105884
[TBL] [Abstract][Full Text] [Related]
23. PEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.
Lejone TI; Kopo M; Bachmann N; Brown JA; Glass TR; Muhairwe J; Matsela T; Scherrer R; Chere L; Namane T; Labhardt ND; Amstutz A
BMC Public Health; 2020 Mar; 20(1):425. PubMed ID: 32228531
[TBL] [Abstract][Full Text] [Related]
24. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.
Meyer-Rath G; Pienaar J; Brink B; van Zyl A; Muirhead D; Grant A; Churchyard G; Watts C; Vickerman P
PLoS Med; 2015 Sep; 12(9):e1001869. PubMed ID: 26327271
[TBL] [Abstract][Full Text] [Related]
26. Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.
Uthman RT; Sutton AJ; Jackson LJ; Uthman OA
PLoS One; 2018; 13(1):e0191465. PubMed ID: 29360841
[TBL] [Abstract][Full Text] [Related]
27. Differentiated models of service delivery for antiretroviral treatment of HIV in sub-Saharan Africa: a rapid review protocol.
Long L; Kuchukhidze S; Pascoe S; Nichols B; Cele R; Govathson C; Huber A; Flynn D; Rosen S
Syst Rev; 2019 Dec; 8(1):314. PubMed ID: 31810482
[TBL] [Abstract][Full Text] [Related]
28. Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future "test and start" strategies.
Vyas S; Songo J; Guinness L; Dube A; Geis S; Kalua T; Todd J; Renju J; Crampin A; Wringe A
BMC Health Serv Res; 2020 Aug; 20(1):740. PubMed ID: 32787835
[TBL] [Abstract][Full Text] [Related]
29. Cost implications of HIV retesting for verification in Africa.
Lasry A; Kalou MB; Young PR; Rurangirwa J; Parekh B; Behel S
PLoS One; 2019; 14(7):e0218936. PubMed ID: 31260467
[TBL] [Abstract][Full Text] [Related]
30. "Conditional scholarships" for HIV/AIDS health workers: educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa.
Bärnighausen T; Bloom DE
Soc Sci Med; 2009 Feb; 68(3):544-51. PubMed ID: 19081662
[TBL] [Abstract][Full Text] [Related]
31. Human resources for treating HIV/AIDS: needs, capacities, and gaps.
Bärnighausen T; Bloom DE; Humair S
AIDS Patient Care STDS; 2007 Nov; 21(11):799-812. PubMed ID: 17944556
[TBL] [Abstract][Full Text] [Related]
32. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
[TBL] [Abstract][Full Text] [Related]
33. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
[TBL] [Abstract][Full Text] [Related]
34. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review.
Long L; Kuchukhidze S; Pascoe S; Nichols BE; Fox MP; Cele R; Govathson C; Huber AN; Flynn D; Rosen S
J Int AIDS Soc; 2020 Nov; 23(11):e25640. PubMed ID: 33247517
[TBL] [Abstract][Full Text] [Related]
35. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
[TBL] [Abstract][Full Text] [Related]
36. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda.
Guthrie T; Muheki C; Rosen S; Kanoowe S; Lagony S; Greener R; Miot J; Balidawa H; Kiggundu J; Calnan J; Dejene S; Xulu T; Sigwebela N; Long LC
BMC Health Serv Res; 2022 Nov; 22(1):1315. PubMed ID: 36329450
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.
Zürcher K; Mooser A; Anderegg N; Tymejczyk O; Couvillon MJ; Nash D; Egger M;
Trop Med Int Health; 2017 Apr; 22(4):375-387. PubMed ID: 28102610
[TBL] [Abstract][Full Text] [Related]
38. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness and Budget Impact Analysis of the Implementation of Differentiated Service Delivery Models for HIV Treatment in Mozambique: a Modelling Study.
Moiana Uetela DA; Zimmermann M; Chicumbe S; Gudo ES; Barnabas R; Uetela OA; Dinis A; Augusto O; Gaveta S; Couto A; Gaspar I; Macul H; Hughes JP; Gimbel S; Sherr K
J Int AIDS Soc; 2024 May; 27(5):e26275. PubMed ID: 38801731
[TBL] [Abstract][Full Text] [Related]
40. Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
Geldsetzer P; Francis JM; Sando D; Asmus G; Lema IA; Mboggo E; Koda H; Lwezaula S; Ambikapathi R; Fawzi W; Ulenga N; Bärnighausen T
PLoS Med; 2018 Sep; 15(9):e1002659. PubMed ID: 30231024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
